Windtree Therapeutics, Inc. Profile Avatar - Palmy Investing

Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include ist…

Biotechnology
US, Warrington [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of WINT's Analysis
CIK: 946486 CUSIP: 97382D303 ISIN: US97382D4025 LEI: - UEI: -
Secondary Listings
WINT has no secondary listings inside our databases.